SteadyMed Provides Insights on Recent Corporate Developments and Reports Second Quarter 2015 Financial Results
13 août 2015 16h05 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., Aug. 13, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (NASDAQ:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value...